PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Collaborative preclinical efficacy studies suggest a new target for drug addiction treatment

2012-03-15
(Press-News.org) In preclinical studies, researchers at SRI International and Astraea Therapeutics have recently evaluated the role of a new drug receptor target that shows promise for the treatment of drug addiction.

This potential new drug target belongs to a class of receptors called the nicotinic acetylcholine receptors (nAChRs). One subtype of nAChRs, called alpha4beta2 is a well-known target for nicotine's addictive effects and the therapeutic effect of the smoking cessation drug varenicline. SRI researchers are now studying another, lesser-known subtype, called alpha3beta4 nAChR, which has recently shown to play a role in the addictive properties of cocaine, morphine, and nicotine.

Using AT-1001, a highly selective alpha3beta4 compound developed by Astraea Therapeutics, SRI researchers found that addiction processes could be disrupted. In preliminary studies, AT-1001 also reduced nicotine withdrawal symptoms such as anxiety.

Because addictive drugs act on the brain's "reward circuit," many people compulsively take them despite their harmful consequences. Feelings of pleasure are caused by the release of brain chemicals, or neurotransmitters, and their increased activity in the brain reward circuit. The key neurotransmitter in the reward circuit is dopamine, which produces changes in addictive behavior. Researchers speculate that disruption of the alpha3beta4 nAChR system using highly selective drugs such as AT-1001 may interrupt this reward circuitry.

"Currently, there are no therapeutics approved to treat addiction to stimulants such as cocaine, so it is intriguing to find a promising drug receptor target and to see that AT-1001 can indeed affect phenomena that are thought to be deeply tied to the addictive nature of cocaine and other drugs of abuse," said Taline Khroyan, Ph.D., Senior Behavioral Pharmacologist in SRI's Center for Health Sciences.

Findings from these collaborative studies were recently presented at the Society for Neuroscience Annual Meeting in a study titled "AT-1001, a Highly Selective alpha3beta4 nicotinic Receptor Antagonist is Effective in Blocking Place Preference, Behavioral Sensitization, and Withdrawal Effects of Various Drugs of Abuse." The presentation was highlighted by the Society for describing the innovative approach taken by the research team.

INFORMATION:

This research was funded 96% ($1,991,814) by National Institute on Drug Abuse grant R01DA020811. The remainder is from non-governmental sources.

About SRI International

Silicon Valley-based SRI International, a nonprofit research and development organization, performs sponsored R&D for governments, businesses, and foundations. SRI brings its innovations to the marketplace through technology licensing, new products, and spin-off ventures. SRI is known for world-changing innovations in computing, health and pharmaceuticals, chemistry and materials, sensing, energy, education, national defense, and more.

END



ELSE PRESS RELEASES FROM THIS DATE:

What to Do When Nursing Home Neglect Leads to Dangerous Dehydration

2012-03-15
Dehydration is one of the most common forms of nursing home neglect. The risk of dehydration is particularly acute in patients who suffer from health problems that render them incapable of properly communicating their needs. Nursing home dehydration can happen for a number of different reasons. Some patients aren't physically able to drink from a glass, either because they have difficulty swallowing or because they are unable to sit upright. In other cases, patients with cognitive or emotional difficulties may refuse certain beverages. In the worst cases the neglect ...

More than half of Americans doubt US global leadership in 2020

2012-03-15
WASHINGTON—March 14, 2012—More than half of likely voters doubt that the United States will be the No. 1 world leader in science, technology and health care by the year 2020, according to a new national public opinion poll commissioned by Research!America. The findings reveal deep concerns among Americans about the country's ability to maintain its world-class status in innovation, research and development before the next decade. "A lackluster investment in science and innovation is driving fears among Americans about our world dominance in the years ahead," said Research!America ...

Study demonstrates cells can acquire new functions through transcriptional regulatory network

2012-03-15
Researchers at the RIKEN Omics Science Center (OSC) have successfully developed and demonstrated a new experimental technique for producing cells with specific functions through the artificial reconstruction of transcriptional regulatory networks. As an alternative to induced pluripotent stem cells, the technique promises to enable faster and more efficient production of functional cells for use in cancer therapy and a variety of other areas. Starting with the first-ever production of induced pluripotent stem cells (iPS cells) in 2006, cell reprogramming - the genetic ...

Genome-wide study reveals how key immune sensors arrive at the front lines of infection

Genome-wide study reveals how key immune sensors arrive at the front lines of infection
2012-03-15
LA JOLLA, Calif., March 14, 2012 – In a healthy immune system, invading pathogens trigger a cascade of alerts and responses to fight off the infection. Sensors called toll-like receptors, or TLRs, act as one of the first lines of defense. Two of these sensors, known as TLR7 and TLR9, specifically recognize and respond to microbial RNA and DNA, respectively. But what determines how these TLRs get where they need to be and sound the alarm for pathogen infection? To answer this question, a team led by Sumit Chanda, Ph.D. and colleagues at Sanford-Burnham Medical Research Institute ...

Breakthroughs in Chikungunya research from A*STAR spell new hope for better treatment and protection

2012-03-15
Recent breakthroughs in Chikungunya research spearheaded by scientists at A*STAR's Singapore Immunology Network (SIgN) have made great strides in the battle against the infectious disease. Working in close collaborations with Singapore clinician-scientists and international researchers , Dr Lisa Ng, Principal Investigator of the Chikungunya research group at SIgN, led the team to discover a direct biomarker which serves as an early and accurate prognosis of patients who have a higher risk of the more severe form of Chikungunya fever (CHIKF). This means that doctors can ...

Texas Paternity Fraud: I'm Not the Father So Why the Child Support?

2012-03-15
What if a man has been named the father of a child, but has to pay child support because he missed court or was misled into signing a paternity statement without a DNA test? Although the Texas Family Code covers a wide range of legal issues from divorce, child custody and spousal support to modifications of custody and visitation because of parental relocation, one Texas paternity provision was recently changed regarding the need to correct paternity mistakes with DNA testing. Prior to the passage of Texas Senate Bill 785, a man could only request a paternity test prior ...

UN emission market needs urgent reform

2012-03-15
The United Nations (UN) global carbon market requires substantial reform because it too often fails to support the projects and people it is meant to help, according to new research from the Economic and Social Research Council (ESRC). The research findings are released as the UN, which has designated 2012 the International Year of Sustainable Energy for All, begins a policy dialogue about its Clean Development Mechanism (CDM), under which companies are allocated tradable credits if they pay others to cut their carbon emissions. The CDM is designed to help finance ...

Anesthetists test scale that measures risk of harm from invasive research placebos

2012-03-15
A scale developed to measure the potential harm caused by invasive placebos in local anaesthesia research has been successfully tested by a group of 43 independent clinicians, according to research published in the April issue of Anaesthesia. The consultant anaesthetists were asked to assess the risk of harm posed by control group interventions described in ten published clinical anaesthesia studies using the Serious Harm and Morbidity (SHAM) scale. There was substantial agreement between the 22 consultants who were given clinical examples to illustrate the scale ...

Change on the Horizon for Small Claim Copyright Infringement?

2012-03-15
An exclusive right to produced work is cemented within the Constitution. When works of art, works of authorship or screenplays are produced, the creators have the right to protect their works. These protections are provided by the federal Copyright Act, which has a broad reach, including both small, individual works and colossal, multimillion-dollar movie productions. Just as the range of protected work varies, so do the resources available to bring lawsuits claiming copyright infringement. Those attempting to file suits for relatively small claims are often dissuaded ...

Researchers attempt to solve problems of antibiotic resistance and bee deaths in one

2012-03-15
The stomachs of wild honey bees are full of healthy lactic acid bacteria that can fight bacterial infections in both bees and humans. A collaboration between researchers at three universities in Sweden – Lund University, the Swedish University of Agricultural Sciences and Karolinska Institutet – has produced findings that could be a step towards solving the problems of both bee deaths and antibiotic resistance. The researchers have now published their results in the scientific journal PLoS ONE and the legendary science photographer Professor Lennart Nilsson from Karolinska ...

LAST 30 PRESS RELEASES:

The Journal of Nuclear Medicine Ahead-of-Print Tip Sheet: May 9, 2025

Stability solution brings unique form of carbon closer to practical application

New research illustrates the relationship between moral outrage on social media and activism

New enzyme capable of cleaving cellulose should revolutionize biofuel production

Krebs von den Lungen-6 as a biomarker for distinguishing between interstitial lung disease and interstitial lung abnormalities based on computed tomography findings

Chimpanzee groups drum with distinct rhythms

Wasp mums use remarkable memory when feeding offspring

Americans’ use of illicit opioids is higher than previously reported

Estimates of illicit opioid use in the U.S.

Effectiveness and safety of RSV vaccine for U.S. adults age 60 or older

Mass General Brigham researchers share tool to improve newborn genetic screening

Can frisky flies save human lives?

Heart rhythm disorder traced to bacterium lurking in our gums

American Society of Plant Biologists names 2025 award recipients

Protecting Iceland’s towns from lava flows – with dirt

Noninvasive intracranial source signal localization and decoding with high spatiotemporal resolution

A smarter way to make sulfones: Using molecular oxygen and a functional catalyst

Self-assembly of a large metal-peptide capsid nanostructure through geometric control

Fatty liver in pregnancy may increase risk of preterm birth

World record for lithium-ion conductors

Researchers map 7,000-year-old genetic mutation that protects against HIV

KIST leads next-generation energy storage technology with development of supercapacitor that overcomes limitations

Urine, not water for efficient production of green hydrogen

Chip-scale polydimethylsiloxane acousto-optic phase modulator boosts higher-resolution plasmonic comb spectroscopy

Blood test for many cancers could potentially thwart progression to late stage in up to half of cases

Women non-smokers still around 50% more likely than men to develop COPD

AI tool uses face photos to estimate biological age and predict cancer outcomes

North Korea’s illegal wildlife trade threatens endangered species

Health care workers, firefighters have increased PFAS levels, study finds

Turning light into usable energy

[Press-News.org] Collaborative preclinical efficacy studies suggest a new target for drug addiction treatment